UPF3B antibodies are reagents designed to target the UPF3B protein, a component of the NMD machinery that degrades mRNAs containing premature termination codons (PTCs). These antibodies enable researchers to investigate UPF3B's expression, localization, and interactions in cellular contexts .
Key Functions of UPF3B:
Facilitates NMD by bridging exon junction complexes (EJCs) with downstream effectors like UPF2 and UPF1 .
Regulates immune gene expression in olfactory sensory neurons (OSNs) and maintains olfactory receptor diversity .
Modulates endoplasmic reticulum (ER) stress by interacting with IRE1α, impacting ER-associated degradation .
UPF3B is essential for RNA surveillance, with mutations linked to X-linked intellectual disability (XLID) and neurodevelopmental disorders .
Olfactory Sensory Neurons (OSNs):
UPF3B loss disrupts OSN subsets and upregulates antimicrobial genes, suggesting a role in innate immunity .
ER Stress Modulation:
UPF3B inhibits IRE1α kinase activity, linking NMD to ER stress adaptation .
UPF3A compensates for UPF3B loss in NMD, maintaining mRNA surveillance in UPF3B-deficient cells .
Functional redundancy analysis:
Perform co-depletion experiments (UPF3A + UPF3B siRNA/KO) to assess transcriptome-wide NMD substrate accumulation via RNA-Seq .
Use UPF3B mutants lacking UPF2-binding domains (Δ2BD) to isolate UPF3A-specific contributions .
Rescue assays: Transfect UPF3B/UPF3A domain-swap constructs into dKO cells to map functional regions .
Experimental framework:
Mechanistic studies:
For co-IP studies, include RNase treatment controls to distinguish RNA-dependent/independent interactions .
In murine models, combine antibody validation with transcriptome-wide analysis (e.g., RNA-Seq in Upf3a KO mESCs) .
For clinical correlations, use patient-derived cells with UPF3B mutations to assess antibody utility in diagnostic workflows .